Literature DB >> 15372158

[Identification of possible cognizance parameters of "mimic disintegration" in schizophrenia using facial electromyography].

K Wolf1, S Köppel, R Mass, D Naber.   

Abstract

UNLABELLED: The aim of this study was to identify signs of "mimic disintegration" in schizophrenics using a facial electromyographic (EMG) method. We compared a group of 20 unmedicated schizophrenics with a group of 20 healthy subjects, measuring the activity of three joy-relevant facial muscles (zygomaticus major, orbicularis oculi, levator labii superioris) and two nonjoy-relevant facial muscles (frontalis, corrugator supercilii) as control muscles during two consecutive presentations of an erotic slide from the International Affective Picture System. RESULT: Schizophrenics show significantly less activity of joy-relevant facial muscles and a lower smile frequency than healthy subjects. Two signs of mimic disintegration" could be identified: 1. undefined mimic reactions and 2. lack of mimic consistency.
CONCLUSION: Facial EMG is a state-of-the-art method for analyzing possible signs of mimic disintegration as described by Heimann and Spoerri. We suggest further examination of the two mimic disintegration signs regarding other emotions, necessarily including more facial muscles in the testing.

Entities:  

Mesh:

Year:  2005        PMID: 15372158     DOI: 10.1007/s00115-004-1782-8

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  16 in total

1.  The effects of neuroleptics on facial action in schizophrenic patients.

Authors:  F Schneider; H Ellgring; J Friedrich; I Fus; T Beyer; H Heimann; W Himer
Journal:  Pharmacopsychiatry       Date:  1992-09       Impact factor: 5.788

2.  Interaction regulations used by schizophrenic and psychosomatic patients: studies on facial behavior in dyadic interactions.

Authors:  E Steimer-Krause; R Krause; G Wagner
Journal:  Psychiatry       Date:  1990-08       Impact factor: 2.458

3.  Rapid facial reactions to emotional facial expressions.

Authors:  U Dimberg; M Thunberg
Journal:  Scand J Psychol       Date:  1998-03

4.  Guidelines for human electromyographic research.

Authors:  A J Fridlund; J T Cacioppo
Journal:  Psychophysiology       Date:  1986-09       Impact factor: 4.016

5.  The psychophysiology of disgust: differentiating negative emotional contexts with facial EMG.

Authors:  S R Vrana
Journal:  Psychophysiology       Date:  1993-05       Impact factor: 4.016

6.  Facial reactions to facial expressions.

Authors:  U Dimberg
Journal:  Psychophysiology       Date:  1982-11       Impact factor: 4.016

7.  [The quantitative analysis of facial movements and its application in pharmaco-psychology].

Authors:  H Heimann
Journal:  Arzneimittelforschung       Date:  1966-02

8.  [A method for the quantitative analysis of mimic movements].

Authors:  H Heimann; G Lukàcs
Journal:  Arch Gesamte Psychol       Date:  1966-07

9.  Do schizophrenic patients show a disjunctive relationship among expressive, experiential, and psychophysiological components of emotion?

Authors:  A M Kring; J M Neale
Journal:  J Abnorm Psychol       Date:  1996-05

10.  Symptomatic and neuropsychological components of defect states.

Authors:  R M Bilder; S Mukherjee; R O Rieder; A K Pandurangi
Journal:  Schizophr Bull       Date:  1985       Impact factor: 9.306

View more
  3 in total

Review 1.  [Expression, identification and experience of emotions in mental diseases. An overview].

Authors:  K Wolf; R Maß; M Lambert; K Wiedemann; D Naber
Journal:  Nervenarzt       Date:  2014-03       Impact factor: 1.214

2.  Kinematic analysis of facial behaviour in patients with schizophrenia under emotional stimulation by films with "Mr. Bean".

Authors:  Georg Juckel; R Mergl; A Prässl; P Mavrogiorgou; H Witthaus; H J Möller; U Hegerl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04       Impact factor: 5.270

Review 3.  Measuring facial expression of emotion.

Authors:  Karsten Wolf
Journal:  Dialogues Clin Neurosci       Date:  2015-12       Impact factor: 5.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.